Recombinant Bubalus bubalis Pregnancy-associated glycoprotein 61C

What are Pregnancy-associated glycoproteins (PAGs) in water buffaloes (Bubalus bubalis)?

Pregnancy-associated glycoproteins (PAGs) in water buffaloes are a family of placental proteins synthesized by the mono- and binucleate trophoblastic cells of the fetus. These glycoproteins are secreted during pregnancy and enter the maternal circulation, where they can be detected as early as days 15-22 after fertilization, though detection accuracy improves from days 28-30 onwards . PAGs belong to the aspartic proteinase (AP) family and have been identified in multiple species within the order Cetartiodactyla, including buffaloes. Buffalo PAGs have been isolated, purified, and characterized from placental tissues, revealing multiple isoforms with unique structural and functional characteristics . These glycoproteins serve as important biomarkers for pregnancy diagnosis and can provide insights into fetal well-being and placental function.

How are buffalo PAGs classified and what isoforms have been identified?

Buffalo PAGs are classified into two major phylogenetic groups:

• Ancient PAGs group (PAG-2): Believed to play important roles in implantation and placentation processes .

• Modern PAGs group: Includes most of the identified buffalo PAG isoforms .

A comprehensive study of buffalo PAG isoforms identified a total of 12 distinct isoforms:

Additionally, each isoform presents multiple transcript variants, indicating substantial heterogeneity in their expression .

What is the three-dimensional structure of buffalo PAGs and how does it relate to function?

The three-dimensional structure of BuPAG 7, the most abundant isoform in buffalo placenta, has been determined through homology modeling and molecular dynamic (MD) simulations . Key structural features include:

• A typical fold represented by other aspartic proteinase family members

• A unique 35-41 amino acid insertion near the N-terminus that forms an alpha helix connected by two loops

• This insertion appears to be a distinctive feature of BuPAG 7 within the aspartic proteinase family

Molecular docking studies with Pepstatin inhibitor revealed that BuPAG 7 interacts through various hydrogen bonding and hydrophobic interactions. Various amino acid substitutions were observed in the peptide-binding cleft of BuPAG 7, which may contribute to its specific functions during pregnancy .

The structural analysis suggests that while buffalo PAGs maintain the core aspartic proteinase fold, they have evolved specific structural elements that may relate to their specialized functions in pregnancy maintenance.

What are the proposed biological functions of PAGs in buffalo pregnancy?

Buffalo PAGs are believed to have multiple functions during pregnancy:

• Immunomodulatory role: PAGs may participate in maternal immune tolerance of the fetus by modulating immune responses at the feto-maternal interface .

• Luteotropic activity: Studies have shown that PAGs can induce the release of prostaglandin (PG) E2 and progesterone from luteal cells and PGE2 from endometrial cells. BuPAG-2 has been shown to be similar to LH, forming bonds with CL receptors, suggesting it may represent one of the luteotropic factors of the ruminant placenta .

• Placental remodeling: Due to their active migration from fetal to maternal tissues, PAGs are believed to play an important role in the remodeling of fetal membranes during pregnancy .

• Indicator of fetal well-being: The relationship between PAGs and fetal well-being is understood by considering that these glycoproteins are secreted by trophectoderm cells. This secretion is an active process that requires healthy trophoblastic tissue, and therefore, a healthy embryo .

• Hormonal activities: Austin et al. attributed to PAGs a hormonal role in inducing the release of granulocyte chemotactic protein-2 (GCP-2), an alpha chemokine whose synthesis is induced by interferon-tau (IFN-tau) in early pregnancy .

What expression systems are optimal for producing recombinant buffalo PAGs?

Based on available research and comparable recombinant protein production systems, several expression platforms can be considered for buffalo PAG production:

• E. coli expression system: The bacterial expression system has been successfully used for cloning buffalo PAG mRNAs. As mentioned in search result , PAG mRNAs isolated from fetal cotyledons were successfully cloned in pJET1.2 vector and transformed in E. coli. This system is advantageous for initial cloning and sequencing but may not provide proper post-translational modifications required for fully functional PAGs .

• Mammalian cell expression: For functional studies requiring proper glycosylation and folding, mammalian cell expression systems (such as CHO or HEK293 cells) would be more appropriate. The LOC102412860 gene (pregnancy-associated glycoprotein 2-like) cDNA ORF clone from GenScript utilizes pcDNA3.1+/C-(K)DYK vector, which is designed for mammalian expression .

• Viral vector systems: Recombinant adenovirus systems have been used for other buffalo proteins and could potentially be adapted for PAG expression, particularly when high-level expression in mammalian cells is desired .

When selecting an expression system, researchers should consider that buffalo PAGs are heavily glycosylated proteins, with N-glycosylation playing an important role in their structure and function. The absence of a signal in cycle 4 of N-terminal sequencing, followed by the consensus sequence L-T, is characteristic of the N-glycosylation site in buffalo PAGs .

How can the glycosylation of recombinant PAGs be optimized to match native proteins?

Optimizing glycosylation patterns in recombinant buffalo PAGs requires consideration of several factors:

• Selection of appropriate expression host: Mammalian expression systems (especially those derived from bovine or buffalo cells) would provide glycosylation patterns most similar to native buffalo PAGs. Research has shown that in cattle, the dominant boPAG 67kDa form has 4 potential glycosylation sites and 10% oligosaccharide content .

• Identification of glycosylation sites: N-terminal sequences of buffalo PAGs (wbPAGs) fail to give any signal on cycle 4, with this blank cycle followed by the consensus sequence L-T, which is characteristic of N-glycosylation sites . Ensuring these sites are accessible in the recombinant construct is crucial.

• Glycosylation analysis methods: Techniques such as lectin affinity chromatography with Vicia villosa agglutinin (VVA) have proven valuable for enriching placental glycoproteins produced by binucleate cells . This approach could be used to select properly glycosylated recombinant proteins.

• Media optimization: For mammalian cell culture, supplementing media with specific sugars and glycosylation precursors can help direct the glycosylation process toward desired patterns.

The importance of proper glycosylation cannot be overstated, as it affects protein folding, stability, and biological activity. Research indicates that multi-antennary oligosaccharides may represent a significant portion of the relative molecular mass of PAGs (17.83% in ovine PAGs) .

How should researchers design studies to evaluate buffalo PAG expression patterns during different stages of pregnancy?

To evaluate buffalo PAG expression patterns throughout pregnancy, researchers should design studies with the following considerations:

• Sampling timeline: Based on established PAG profiles, critical sampling points should include:

  • Early pregnancy (days 15-22): Initial detection

  • Days 28-30: When detection accuracy improves

  • Day 105: When PAG levels stabilize in buffalo (unlike bovine where levels continue to increase until parturition)

  • Post-partum period: Days 0, 10, 20, 30, and 50 (PAGs reach minimal values <1 ng/mL by day 30 post-partum in buffalo)

• Sample types and collection:

  • Blood samples for maternal circulation PAGs

  • Placental tissue samples (where possible from different stages)

  • Trophoblastic cells for direct PAG expression analysis

• Control groups:

  • Non-pregnant animals

  • Animals at different parities

  • Animals carrying different numbers of fetuses (single vs. multiple pregnancies)

• Analytical methods:

  • RIA using specific antisera (e.g., RIA-860 system developed specifically for buffalo PAGs)

  • mRNA expression analysis using RT-PCR for specific PAG isoforms

  • Protein analysis through Western blotting with PAG-specific antibodies

• Data analysis approach:

  • Compare PAG concentration profiles between different physiological states

  • Analyze isoform-specific expression patterns

  • Correlate PAG levels with pregnancy outcomes and fetal development

Research by Barbato et al. demonstrated that in buffalo, the PAG concentration increased up to day 105 and then remained constant until parturition, which differs from bovine animals where an exponential increase was observed until parturition . This species-specific pattern must be considered when designing studies.

What controls are necessary when developing radioimmunoassays for buffalo PAG detection?

When developing radioimmunoassays (RIAs) for buffalo PAG detection, several critical controls must be incorporated:

• Specificity controls:

  • Include samples from non-pregnant animals to establish baseline values

  • Test for cross-reactivity with other related proteins (other aspartic proteinases)

  • Evaluate cross-reactivity with PAGs from other species (bovine, ovine, etc.)

• Sensitivity controls:

  • Include known PAG concentrations to establish standard curves

  • Determine minimum detectable limits (MDL)

  • Include samples from early pregnancy stages to evaluate early detection capability

• Reproducibility controls:

  • Evaluate intra-assay coefficient of variation (CV)

  • Evaluate inter-assay CV

  • Include reference samples across multiple assay runs

• Validation controls:

  • Compare RIA results with pregnancy status determined by ultrasonography

  • Calculate sensitivity (ability to correctly identify pregnant animals)

  • Calculate specificity (ability to correctly identify non-pregnant animals)

• Post-partum considerations:

  • Include samples from recently calved animals to determine detection window for post-partum PAG clearance

Research shows that the RIA-860 system (developed with antisera raised against buffalo PAGs) provides high accuracy for diagnosing pregnancy in buffaloes starting from day 28 of gestation. The sensitivity of this system ranged from 23% on day 23 to 98% on day 28 post-AI, with 100% specificity throughout the sampling period . The rapid disappearance of PAG concentrations after calving in buffaloes (below 1 ng/mL from day 30 post-partum) means that, unlike in bovines, a cut-off limit for post-partum is not required for detecting a new pregnancy .

How do different immunoassay systems compare for detecting buffalo PAGs?

Different immunoassay systems have been developed and compared for detecting buffalo PAGs, each with specific characteristics:

Research comparing these systems has shown:

• Barbato et al. compared RIA-497, RIA-706, and RIA-708 for detecting PAG molecules in pregnant buffalo females and reported that PAG antigens were better recognized using RIA-706 from week 6 of gestation onwards .

• The RIA-860 system was developed specifically using antisera raised against buffalo PAG and demonstrated excellent parallelism between serial dilutions of pregnant buffalo samples and the standard curve, indicating it is a good immunoassay for distinguishing subtle quantitative differences in buffalo PAG concentrations .

• The RIA-860 system proved to be very repeatable for measurement of PAG concentrations, with intra- and inter-assay CV lower than 8% .

• The minimum detectable limit (MDL) of RIA-860 was equivalent (0.1 ng/mL) to that previously described for other RIA systems (RIA-497, RIA-706, and RIA-Pool) .

When selecting an immunoassay system, researchers should consider the specific research question, required sensitivity, and available resources.

What are the current challenges in detecting and distinguishing different buffalo PAG isoforms?

Researchers face several challenges when detecting and distinguishing different buffalo PAG isoforms:

• Structural similarities: Multiple PAG isoforms share high sequence homology, making it difficult to develop isoform-specific antibodies or detection methods. For example, the four BuPAG1 sequences recovered from buffalo placenta showed 99.6% to 100% identity among themselves .

• Temporal expression patterns: Different PAG isoforms are expressed at different stages of pregnancy. BuPAG 7 was found to be the most abundant isoform across all studied pregnancy stages (45, 75, and 90 days), followed by BuPAG 18 .

• Post-translational modifications: Extensive glycosylation of PAGs contributes to their heterogeneity and complicates precise identification. N-terminal sequences of buffalo PAGs fail to give signals on cycle 4, indicating N-glycosylation sites .

• Multiple transcript variants: Each PAG isoform can present multiple transcript variants, further increasing complexity. A study that sequenced 360 random clones identified numerous variants for most buffalo PAG isoforms .

• Cross-reactivity in immunoassays: Antibodies developed against one PAG isoform often cross-react with others, making specific quantification challenging.

Current approaches to address these challenges include:

• Molecular techniques like isoform-specific PCR primers for mRNA expression analysis

• Proteomic approaches combining high-resolution chromatography with mass spectrometry

• Development of monoclonal antibodies targeting unique epitopes of specific isoforms

• Three-dimensional structure analysis to identify unique structural features of different isoforms, such as the 35-41 amino acid insertion identified in BuPAG 7

Future research should focus on developing more specific detection methods and characterizing the functional differences between these isoforms to better understand their biological significance.

How can recombinant buffalo PAGs be used to improve pregnancy diagnosis protocols in water buffaloes?

Recombinant buffalo PAGs offer several advantages for improving pregnancy diagnosis protocols in water buffaloes:

• Standardization of detection assays: Using recombinant proteins as standards in immunoassays ensures consistent calibration across laboratories and studies. This standardization is critical for establishing reliable cut-off values for pregnancy determination.

• Development of isoform-specific assays: Recombinant production of specific PAG isoforms allows the development of isoform-targeted diagnostic assays. Research has shown that different PAG isoforms have distinct expression patterns during pregnancy, with BuPAG 7 being the most abundant isoform across all stages studied .

• Improved early detection methods: By focusing on early-expressed PAG isoforms, researchers can develop more sensitive early pregnancy detection methods. Current research shows PAGs can be detected in maternal blood as early as days 15-22 after fertilization, with accuracy improving from days 28-30 .

• Field-applicable diagnostic kits: Recombinant PAGs can be used to develop simplified diagnostic kits suitable for field applications in buffalo farming. The rapid disappearance of PAGs from maternal circulation in buffaloes (reaching <1 ng/mL by day 30 post-partum) means that, unlike in cattle, there is no need for a cut-off limit in post-partum animals for detecting a new pregnancy .

• Differential diagnosis capabilities: Assays incorporating multiple recombinant PAG isoforms could potentially distinguish normal pregnancies from abnormal conditions, as PAG expression is linked to fetal well-being and placental health .

Implementation considerations:

• The optimal testing window for buffalo pregnancy diagnosis using PAGs appears to be from day 28 post-insemination onwards, when the RIA-860 system shows 98-99% accuracy .

• In buffaloes with a voluntary waiting period of at least 50 days post-partum, residual PAGs from previous pregnancies are unlikely to interfere with new pregnancy diagnosis, unlike in cattle where PAGs can persist for 80-100 days .

What is the relationship between PAG expression patterns and fetal development or pregnancy outcomes in buffaloes?

The relationship between PAG expression patterns and fetal development or pregnancy outcomes in buffaloes reveals important clinical applications:

These relationships highlight the potential of PAG profiling not just for pregnancy diagnosis but also as a tool for monitoring fetal health and predicting pregnancy outcomes in buffalo reproductive management.

What are promising approaches for developing multi-functional recombinant buffalo PAG proteins for research applications?

Several promising approaches can advance the development of multi-functional recombinant buffalo PAG proteins for research:

• Domain-specific engineering: Analyzing the functional domains of buffalo PAGs, particularly the unique 35-41 amino acid insertion near the N-terminus of BuPAG 7 , could allow for targeted modifications to enhance specific properties while preserving others.

• Chimeric PAG constructs: Creating chimeric proteins combining domains from different PAG isoforms could yield molecules with multiple functionalities. For example, combining the immunogenic regions of BuPAG 7 (the most abundant isoform) with functional domains of ancient PAGs like BuPAG 2 (important in implantation) .

• Controlled glycosylation: As PAGs are heavily glycosylated proteins, developing expression systems with controlled glycosylation patterns could improve both stability and functionality. N-glycosylation sites have been identified in buffalo PAGs (characterized by absence of signal in cycle 4 of N-terminal sequencing followed by L-T consensus sequence) .

• Fusion protein approaches: Creating fusion proteins combining PAGs with reporter molecules, affinity tags, or functional moieties could expand their research applications. These could include:

  • PAG-fluorescent protein fusions for cellular localization studies

  • PAG-enzyme fusions for amplified detection systems

  • PAG-antibody fragment fusions for targeted delivery

• Stability-enhanced variants: Engineering modifications to improve thermal stability and storage properties while maintaining antigenic properties would benefit diagnostic applications, especially for field use in tropical regions where buffaloes are commonly raised.

Implementation of these approaches would benefit from:

• Detailed 3D structural analysis of multiple buffalo PAG isoforms beyond the BuPAG 7 model already developed

• Comparative functional studies of different natural isoforms to identify key functional regions

• Development of buffalo-specific cell expression systems to ensure proper post-translational modifications

These advances would support both fundamental research into PAG functions and applied diagnostic development for improving buffalo reproductive management.

How might comparative studies between buffalo PAGs and those of other ruminants advance our understanding of placental evolution?

Comparative studies between buffalo PAGs and those of other ruminants provide valuable insights into placental evolution:

• Evolutionary divergence patterns: Buffalo PAGs display distinctive phylogenetic patterns compared to bovine PAGs. For example, BuPAG 7, the most abundant buffalo isoform, contains a unique 35-41 amino acid insertion near the N-terminus that appears to be buffalo-specific . Tracking such molecular innovations across species can reveal evolutionary selection pressures on placental development.

• Functional adaptation analysis: Differences in PAG expression patterns between buffalo and cattle (e.g., buffalo PAG levels stabilize after day 105 of pregnancy while bovine PAGs continue increasing until parturition ) suggest species-specific adaptations in placental function that may reflect different reproductive strategies.

• Structural comparisons: Molecular docking studies of buffalo PAGs have revealed various amino acid substitutions in the peptide-binding cleft compared to other aspartic proteinases . These substitutions may relate to species-specific substrate preferences and functional specialization during evolution.

• Ancient vs. modern PAG comparisons: The division of PAGs into "ancient" (e.g., PAG-2) and "modern" groups across ruminant species provides a framework for understanding the evolutionary history of this gene family . Buffalo-specific patterns in this division could reveal unique selective pressures in the Bubalus lineage.

• Island dwarfism effects: The Bubalus genus includes several species that have undergone island dwarfism (B. mindorensis, B. depressicornis), providing natural experiments in how reproductive adaptations, potentially including PAG expression, evolve under different body size constraints .

• Cross-species placental interfaces: Studies showing that bovine herpesviruses can infect buffalo placenta highlight the comparative susceptibility of placental interfaces across species, which may relate to PAG-mediated immune modulation at the maternal-fetal interface.

Such comparative studies would benefit from:

• Whole-genome sequencing of different Bubalus species to identify PAG gene clusters and regulatory elements

• Transcriptomic analyses of placental tissues across multiple ruminant species at equivalent gestational stages

• Functional studies examining whether PAGs from different species can cross-complement in experimental models

These approaches would provide insights not only into the evolution of PAGs but also into broader patterns of placental adaptation across ruminant evolution.

What are the most effective purification strategies for maximizing yield and purity of recombinant buffalo PAGs?

Purification of recombinant buffalo PAGs requires careful consideration of their biochemical properties. Based on successful approaches with native buffalo PAGs, the following strategies are recommended:

• Affinity chromatography approaches:

  • Lectin affinity chromatography using Vicia villosa agglutinin (VVA) has proven highly effective for enriching placental glycoproteins produced by binucleate cells, including PAGs . This approach specifically targets the glycosylation patterns characteristic of PAGs.

  • Immunoaffinity chromatography using specific anti-PAG antibodies can provide high selectivity, particularly when isoform-specific purification is desired.

• Multi-step purification protocols:
  Based on successful purification of native buffalo PAGs, a multi-step approach is recommended:

  a) Initial extraction and precipitation:

  • Homogenization in appropriate buffer systems

  • Acid precipitation (pH 4.5) followed by ammonium sulfate fractionation (40-80%)

  b) Chromatographic separation sequence:

  • DEAE-cellulose anion exchange chromatography

  • VVA affinity chromatography

  • Gel filtration on Sephadex G75 or similar matrices

  This sequence has been successfully used for the isolation and purification of buffalo PAGs from placental extracts .

• Tag-based systems for recombinant proteins:

  • The LOC102412860 gene (pregnancy-associated glycoprotein 2-like) is available as a cDNA ORF clone with C-terminal DYKDDDDK (FLAG) tags , enabling efficient purification using anti-FLAG affinity resins.

  • Consideration of tag position is crucial, as N-terminal tags might interfere with signal peptide processing and protein folding.

• Optimized elution conditions:

  • For lectin affinity, competitive elution with appropriate carbohydrates

  • For immunoaffinity, gentle elution using pH gradients or chaotropic agents at low concentrations to preserve protein structure

• Post-purification processing:

  • Removal of affinity tags if necessary

  • Buffer exchange into physiologically relevant formulations

  • Concentration using ultrafiltration techniques appropriate for glycoproteins

Yield and purity assessment should include:

• SDS-PAGE with both Coomassie and glycoprotein-specific staining

• Western blotting with PAG-specific antibodies

• Mass spectrometry confirmation of identity and purity

When implementing these strategies, special attention should be paid to maintaining the glycosylation status of the purified proteins, as this is critical for their structural integrity and biological activity.

What are the key considerations for validating the biological activity of recombinant buffalo PAGs?

Validating the biological activity of recombinant buffalo PAGs requires a multi-faceted approach addressing their structural integrity, immunological properties, and functional activities:

• Structural validation:

  • Glycosylation analysis: Compare glycosylation patterns of recombinant PAGs with native proteins using mass spectrometry and lectin binding assays. N-glycosylation is critical, as indicated by the absence of signal in cycle 4 of N-terminal sequencing of native buffalo PAGs .

  • Conformational analysis: Circular dichroism spectroscopy and thermal stability assays to confirm proper protein folding.

  • 3D structure confirmation: Comparison with the established homology model of BuPAG 7, particularly focusing on the unique 35-41 amino acid insertion near the N-terminus that forms an alpha helix connected by two loops .

• Immunological validation:

  • Antigenic recognition: Test reactivity with antibodies raised against native buffalo PAGs in appropriate immunoassay formats.

  • Cross-reactivity analysis: Evaluate recognition by antibodies against PAGs from other species to confirm conserved epitopes.

  • Epitope mapping: Confirm exposure of key antigenic determinants essential for diagnostic applications.

• Functional activity assays based on proposed PAG functions:

  • Protease activity assessment: Though many PAGs have lost enzymatic activity, some may retain it. Evaluate using appropriate substrates and under physiologically relevant conditions.

  • Binding partner interactions: Test interactions with proposed binding partners such as integrin receptors or extracellular matrix components.

  • Hormonal activity: Assess ability to induce release of prostaglandin E2 and progesterone from luteal cells and PGE2 from endometrial cells in vitro, as demonstrated for native PAGs .

  • Immunomodulatory effects: Measure impact on immune cell function, particularly related to maternal immune tolerance mechanisms.

• Cell-based validation:

  • Trophoblast cell migration assays: Test effects on cell migration to validate roles in placental remodeling.

  • Luteotropic activity: Assess effects on luteal cell function in culture models.

  • Signal transduction analysis: Evaluate activation of relevant intracellular signaling pathways in target cells.

• Comparative analysis:

  • Side-by-side comparison with native buffalo PAGs purified from placental tissues.

  • Comparison with recombinant PAGs from other species (bovine, ovine) to identify species-specific activities.

These validation approaches should be prioritized based on the intended application of the recombinant PAGs, whether for basic research, diagnostic development, or therapeutic exploration.

What technical challenges exist in studying buffalo PAG gene expression and protein synthesis?

Researchers face several technical challenges when studying buffalo PAG gene expression and protein synthesis:

• Tissue accessibility limitations:

  • Obtaining placental samples at defined gestational stages requires either slaughter or biopsy, limiting temporal studies in the same animal.

  • Early pregnancy material (days 15-25) is particularly difficult to obtain non-invasively, yet this represents a critical period for PAG expression onset.

  • Tissue heterogeneity within placentomes complicates cell-specific expression analysis.

• PAG family complexity:

  • Extensive multiplicity of buffalo PAG isoforms (at least 12 identified) with many transcript variants for each isoform complicates specific detection .

  • High sequence similarity between isoforms (the four BuPAG1 sequences showed 99.6% to 100% identity) makes designing isoform-specific primers and antibodies challenging .

  • Differentiation between ancient (PAG-2) and modern PAG groups requires specialized approaches.

• Post-translational modification analysis:

  • Extensive and variable glycosylation patterns affect protein mobility in gels and complicate mass spectrometry analysis.

  • N-glycosylation sites (characterized by absence of signal in cycle 4 of N-terminal sequencing) require specialized analysis techniques .

  • Potential phosphorylation and other modifications remain largely unexplored.

• Species-specific reagent limitations:

  • Limited availability of buffalo-specific antibodies and validated qPCR reference genes.

  • Cross-reactivity issues when using reagents developed for bovine studies.

  • Need for buffalo-specific cell lines for functional studies.

• Temporal expression dynamics:

  • Different expression patterns between early (implantation) and late pregnancy.

  • Rapid clearance post-partum (reaching minimal values <1 ng/mL by day 30) requires precise sampling protocols .

  • Distinguishing between maternal circulation PAGs and placental tissue expression.

Potential solutions include:

• Development of buffalo trophoblast cell lines for in vitro studies

• Single-cell RNA sequencing to address tissue heterogeneity

• Long-read sequencing technologies for better differentiation between similar isoforms

• Development of buffalo-specific monoclonal antibodies against key PAG isoforms

• Advanced glycoproteomics approaches for comprehensive PTM characterization

These challenges highlight the need for integrative approaches combining genomics, transcriptomics, proteomics, and functional studies to fully understand buffalo PAG biology.

What are the current limitations in applying PAG-based diagnostic approaches in field conditions?

Despite their promise as pregnancy biomarkers, PAG-based diagnostic approaches face several limitations when applied in field conditions for buffalo reproductive management:

• Timing constraints:

  • Although PAGs can be detected as early as days 15-22 after fertilization, reliable accuracy (98%) is only achieved from day 28 onwards .

  • This timing may not provide a significant advantage over ultrasonography in some management systems.

  • The optimal testing window requires precise knowledge of insemination dates, which may be challenging in natural breeding systems.

• Assay complexity and infrastructure requirements:

  • Current gold standard methods like RIA-860 require specialized laboratory equipment, including radioactive material handling capabilities .

  • ELISA alternatives may offer field applicability but potentially with reduced sensitivity.

  • Sample processing (serum or plasma separation) requires basic laboratory equipment not always available in field settings.

• Biological variation factors:

  • Individual animal variation in PAG concentrations, even at the same gestational stage.

  • Potential influence of parity, nutritional status, and environmental factors on PAG expression.

  • Limited data on how stress or disease conditions might affect PAG profiles in buffaloes.

• Interpretation challenges:

  • Need for established threshold values specific to buffalo breeds and management systems.

  • Potential for false positives due to early embryonic mortality (PAGs may remain detectable briefly after embryo loss).

  • Potential cross-reactivity with PAGs from other species in mixed farming systems.

• Economic considerations:

  • Cost-effectiveness compared to alternative methods (ultrasonography, progesterone assays).

  • Balance between sensitivity, specificity, and cost for routine implementation.

  • Investment in training personnel for sample collection and result interpretation.

Future directions to address these limitations include:

• Development of simplified lateral flow immunoassays using recombinant buffalo PAGs as standards

• Validation of pooled sampling approaches to reduce per-animal testing costs

• Integration with mobile technologies for result recording and interpretation

• Establishment of buffalo-specific reference ranges accounting for breed, parity, and environmental factors

• Combined biomarker approaches incorporating PAGs with other pregnancy indicators for improved accuracy

Addressing these limitations would enhance the practical utility of PAG-based diagnostics in buffalo management systems, particularly in resource-limited settings where buffaloes are commonly raised.